AI Summary
- Increased prescribing of GLP-1 receptor agonists has led to misuse and off-label weight loss use among people with eating disorders.
- Use can exacerbate restrictive behaviour, bingeing, psychiatric symptoms and cause serious medical complications requiring urgent attention.
- Clinicians should screen for eating disorders, avoid sole weight-centric prescribing, and employ multidisciplinary monitoring and patient education.
JAMA Psychiatry. 2026 Jun 24. doi: 10.1001/jamapsychiatry.2026.1716. Online ahead of print.
NO ABSTRACT
PMID:42340738 | DOI:10.1001/jamapsychiatry.2026.1716
Share Evidence Blueprint
Search Google Scholar
Save as PDF
RAISR4D Evidence Matrix
